International Journal of Cancer Management

Published by: Kowsar

Combinational Use of Phytochemicals and Chemotherapeutic Drugs Enhance Their Therapeutic Potential on Human Cervical Cancer Cells

Madhumitha Kedhari Sundaram 1 , Ritu Raina 1 , Nazia Afroze 1 , Apurva Dhupkar 1 , Naval Preet Kaur 1 , Aditya Arte 1 , Firdos Alam Khan 2 and Arif Hussain ORCID 1 , *
Authors Information
1 School of Life Sciences, Manipal Academy of Higher Education, Dubai, United Arab Emirates
2 Institute for Research and Medical Consultations, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia
Article information
  • International Journal of Cancer Management: June 30, 2019, 12 (6); e91783
  • Published Online: June 22, 2019
  • Article Type: Research Article
  • Received: March 23, 2019
  • Revised: May 20, 2019
  • Accepted: May 22, 2019
  • DOI: 10.5812/ijcm.91783

To Cite: Sundaram M K, Raina R, Afroze N, Dhupkar A, Kaur N P, et al. Combinational Use of Phytochemicals and Chemotherapeutic Drugs Enhance Their Therapeutic Potential on Human Cervical Cancer Cells, Int J Cancer Manag. 2019 ; 12(6):e91783. doi: 10.5812/ijcm.91783.

Copyright © 2019, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. DeVita VT Jr, Chu E. A history of cancer chemotherapy. Cancer Res. 2008;68(21):8643-53. doi: 10.1158/0008-5472.CAN-07-6611. [PubMed: 18974103].
  • 2. Tao JJ, Visvanathan K, Wolff AC. Long term side effects of adjuvant chemotherapy in patients with early breast cancer. Breast. 2015;24 Suppl 2:S149-53. doi: 10.1016/j.breast.2015.07.035. [PubMed: 26299406]. [PubMed Central: PMC4743500].
  • 3. Beaver CC, Magnan MA. Managing chemotherapy side effects: Achieving reliable and equitable outcomes. Clin J Oncol Nurs. 2016;20(6):589-91. doi: 10.1188/16.CJON.589-591. [PubMed: 27857268].
  • 4. Huang WC, Chen CY, Lin SJ, Chang CS. Medication adherence to oral anticancer drugs: Systematic review. Expert Rev Anticancer Ther. 2016;16(4):423-32. doi: 10.1586/14737140.2016.1159515. [PubMed: 26935964].
  • 5. Barthelemy P, Asmane-De la Porte I, Meyer N, Duclos B, Serra S, Dourthe LM, et al. Adherence and patients' attitudes to oral anticancer drugs: A prospective series of 201 patients focusing on targeted therapies. Oncology. 2015;88(1):1-8. doi: 10.1159/000366226. [PubMed: 25247774].
  • 6. Torresan MM, Garrino L, Borraccino A, Macchi G, De Luca A, Dimonte V. Adherence to treatment in patient with severe cancer pain: A qualitative enquiry through illness narratives. Eur J Oncol Nurs. 2015;19(4):397-404. doi: 10.1016/j.ejon.2015.01.001. [PubMed: 25691299].
  • 7. Cornelison R, Llaneza DC, Landen CN. Emerging therapeutics to overcome chemoresistance in epithelial ovarian cancer: A mini-review. Int J Mol Sci. 2017;18(10). doi: 10.3390/ijms18102171. [PubMed: 29057791]. [PubMed Central: PMC5666852].
  • 8. Pan ST, Li ZL, He ZX, Qiu JX, Zhou SF. Molecular mechanisms for tumour resistance to chemotherapy. Clin Exp Pharmacol Physiol. 2016;43(8):723-37. doi: 10.1111/1440-1681.12581. [PubMed: 27097837].
  • 9. Huang WY, Cai YZ, Zhang Y. Natural phenolic compounds from medicinal herbs and dietary plants: Potential use for cancer prevention. Nutr Cancer. 2010;62(1):1-20. doi: 10.1080/01635580903191585. [PubMed: 20043255].
  • 10. Hussain A, Harish G, Prabhu SA, Mohsin J, Khan MA, Rizvi TA, et al. Inhibitory effect of genistein on the invasive potential of human cervical cancer cells via modulation of matrix metalloproteinase-9 and tissue inhibitors of matrix metalloproteinase-1 expression. Cancer Epidemiol. 2012;36(6):e387-93. doi: 10.1016/j.canep.2012.07.005. [PubMed: 22884883].
  • 11. Shen X, Zhang Y, Feng Y, Zhang L, Li J, Xie YA, et al. Epigallocatechin-3-gallate inhibits cell growth, induces apoptosis and causes S phase arrest in hepatocellular carcinoma by suppressing the AKT pathway. Int J Oncol. 2014;44(3):791-6. doi: 10.3892/ijo.2014.2251. [PubMed: 24402647].
  • 12. Panda AK, Chakraborty D, Sarkar I, Khan T, Sa G. New insights into therapeutic activity and anticancer properties of curcumin. J Exp Pharmacol. 2017;9:31-45. doi: 10.2147/JEP.S70568. [PubMed: 28435333]. [PubMed Central: PMC5386596].
  • 13. Bal DG, Foerster SB, Backman DR, Lyman DO. Dietary change and cancer: Challenges and future direction. J Nutr. 2001;131(1):181S-5S. doi: 10.1093/jn/131.1.181S. [PubMed: 11208961].
  • 14. Chou TC, Talalay P. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul. 1984;22:27-55. doi: 10.1016/0065-2571(84)90007-4. [PubMed: 6382953].
  • 15. Eom DW, Lee JH, Kim YJ, Hwang GS, Kim SN, Kwak JH, et al. Synergistic effect of curcumin on epigallocatechin gallate-induced anticancer action in PC3 prostate cancer cells. BMB Rep. 2015;48(8):461-6. doi: 10.5483/bmbrep.2015.48.8.216. [PubMed: 25441423]. [PubMed Central: PMC4576954].
  • 16. Chung SS, Vadgama JV. Curcumin and epigallocatechin gallate inhibit the cancer stem cell phenotype via down-regulation of STAT3-NFkappaB signaling. Anticancer Res. 2015;35(1):39-46. [PubMed: 25550533]. [PubMed Central: PMC4290892].
  • 17. Florea AM, Busselberg D. Cisplatin as an anti-tumor drug: Cellular mechanisms of activity, drug resistance and induced side effects. Cancers (Basel). 2011;3(1):1351-71. doi: 10.3390/cancers3011351. [PubMed: 24212665]. [PubMed Central: PMC3756417].
  • 18. Longley DB, Harkin DP, Johnston PG. 5-fluorouracil: Mechanisms of action and clinical strategies. Nat Rev Cancer. 2003;3(5):330-8. doi: 10.1038/nrc1074. [PubMed: 12724731].
  • 19. Park SY, Kim GY, Bae SJ, Yoo YH, Choi YH. Induction of apoptosis by isothiocyanate sulforaphane in human cervical carcinoma HeLa and hepatocarcinoma HepG2 cells through activation of caspase-3. Oncol Rep. 2007;18(1):181-7. doi: 10.3892/or.18.1.181. [PubMed: 17549366].
  • 20. Hussain A, Mohsin J, Prabhu SA, Begum S, Nusri Qel A, Harish G, et al. Sulforaphane inhibits growth of human breast cancer cells and augments the therapeutic index of the chemotherapeutic drug, gemcitabine. Asian Pac J Cancer Prev. 2013;14(10):5855-60. doi: 10.7314/apjcp.2013.14.10.5855. [PubMed: 24289589].
  • 21. Hussain A, Priyani A, Sadrieh L, Brahmbhatt K, Ahmed M, Sharma C. Concurrent sulforaphane and eugenol induces differential effects on human cervical cancer cells. Integr Cancer Ther. 2012;11(2):154-65. doi: 10.1177/1534735411400313. [PubMed: 21382956].
  • 22. Shah PM, Vishnu PV, Gayathri R. Quercetin-a flavonoid: A systematic review. J Pharmceutical Sci Res. 2016:870-80.
  • 23. Wang R, Yang L, Li S, Ye D, Yang L, Liu Q, et al. Quercetin inhibits breast cancer stem cells via downregulation of aldehyde dehydrogenase 1A1 (ALDH1A1), chemokine receptor type 4 (CXCR4), mucin 1 (MUC1), and epithelial cell adhesion molecule (EpCAM). Med Sci Monit. 2018;24:412-20. doi: 10.12659/msm.908022. [PubMed: 29353288]. [PubMed Central: PMC5788241].
  • 24. Nam JS, Sharma AR, Nguyen LT, Chakraborty C, Sharma G, Lee SS. Application of bioactive quercetin in oncotherapy: From nutrition to nanomedicine. Molecules. 2016;21(1). E108. doi: 10.3390/molecules21010108. [PubMed: 26797598]. [PubMed Central: PMC6273093].
  • 25. Sharma C, Sadrieh L, Priyani A, Ahmed M, Hassan AH, Hussain A. Anti-carcinogenic effects of sulforaphane in association with its apoptosis-inducing and anti-inflammatory properties in human cervical cancer cells. Cancer Epidemiol. 2011;35(3):272-8. doi: 10.1016/j.canep.2010.09.008. [PubMed: 20956097].
  • 26. Sundaram M, Raina R, Afroze N, Bajbouj K, Hamad M, Haque S, et al. Quercetin modulates signaling pathways and induces apoptosis in cervical cancer cells. Biosci Rep. 2019;Forthcoming.
  • 27. Matsuura N, Miyamae Y, Yamane K, Nagao Y, Hamada Y, Kawaguchi N, et al. Aged garlic extract inhibits angiogenesis and proliferation of colorectal carcinoma cells. J Nutr. 2006;136(3 Suppl):842S-6S. doi: 10.1093/jn/136.3.842S. [PubMed: 16484577].
  • 28. Sharma C, Vas AJ, Goala P, Gheewala TM, Rizvi TA, Hussain A. Ethanolic neem (azadirachta indica) leaf extract prevents growth of MCF-7 and hela cells and potentiates the therapeutic index of cisplatin. J Oncol. 2014;2014:321754. doi: 10.1155/2014/321754. [PubMed: 24624140]. [PubMed Central: PMC3929266].
  • 29. Rejhova A, Opattova A, Cumova A, Sliva D, Vodicka P. Natural compounds and combination therapy in colorectal cancer treatment. Eur J Med Chem. 2018;144:582-94. doi: 10.1016/j.ejmech.2017.12.039. [PubMed: 29289883].
  • 30. Ben-Arye E, Schiff E, Steiner M, Silbermann M. Wheatgrass in Afifi's garden: Sprouting integrative oncology collaborations in the Middle East. J Clin Oncol. 2011;29(7):944-6. doi: 10.1200/JCO.2010.33.4532. [PubMed: 21220607].
  • 31. Fantini M, Benvenuto M, Masuelli L, Frajese GV, Tresoldi I, Modesti A, et al. In vitro and in vivo antitumoral effects of combinations of polyphenols, or polyphenols and anticancer drugs: Perspectives on cancer treatment. Int J Mol Sci. 2015;16(5):9236-82. doi: 10.3390/ijms16059236. [PubMed: 25918934]. [PubMed Central: PMC4463587].
  • 32. Sorenson CM, Barry MA, Eastman A. Analysis of events associated with cell cycle arrest at G2 phase and cell death induced by cisplatin. J Natl Cancer Inst. 1990;82(9):749-55. doi: 10.1093/jnci/82.9.749. [PubMed: 1691303].
  • 33. Qin LF, Ng IO. Induction of apoptosis by cisplatin and its effect on cell cycle-related proteins and cell cycle changes in hepatoma cells. Cancer Lett. 2002;175(1):27-38. doi: 10.1016/S0304-3835(01)00720-0. [PubMed: 11734333].
  • 34. Maldonado V, Melendez-Zajgla J, Ortega A. Modulation of NF-kappa B, and Bcl-2 in apoptosis induced by cisplatin in HeLa cells. Mutat Res. 1997;381(1):67-75. doi: 10.1016/S0027-5107(97)00150-4. [PubMed: 9403032].
  • 35. Vidya Priyadarsini R, Senthil Murugan R, Maitreyi S, Ramalingam K, Karunagaran D, Nagini S. The flavonoid quercetin induces cell cycle arrest and mitochondria-mediated apoptosis in human cervical cancer (HeLa) cells through p53 induction and NF-kappaB inhibition. Eur J Pharmacol. 2010;649(1-3):84-91. doi: 10.1016/j.ejphar.2010.09.020. [PubMed: 20858478].
  • 36. Pyeon D, Pearce SM, Lank SM, Ahlquist P, Lambert PF. Establishment of human papillomavirus infection requires cell cycle progression. PLoS Pathog. 2009;5(2). e1000318. doi: 10.1371/journal.ppat.1000318. [PubMed: 19247434]. [PubMed Central: PMC2642596].
  • 37. Yi JL, Shi S, Shen YL, Wang L, Chen HY, Zhu J, et al. Myricetin and methyl eugenol combination enhances the anticancer activity, cell cycle arrest and apoptosis induction of cis-platin against HeLa cervical cancer cell lines. Int J Clin Exp Pathol. 2015;8(2):1116-27. [PubMed: 25972998]. [PubMed Central: PMC4396221].
  • 38. Jakubowicz-Gil J, Paduch R, Piersiak T, Glowniak K, Gawron A, Kandefer-Szerszen M. The effect of quercetin on pro-apoptotic activity of cisplatin in HeLa cells. Biochem Pharmacol. 2005;69(9):1343-50. doi: 10.1016/j.bcp.2005.01.022. [PubMed: 15826605].
  • 39. Pradhan SJ, Mishra R, Sharma P, Kundu GC. Quercetin and sulforaphane in combination suppress the progression of melanoma through the down-regulation of matrix metalloproteinase-9. Exp Ther Med. 2010;1(6):915-20. doi: 10.3892/etm.2010.144. [PubMed: 22993618]. [PubMed Central: PMC3446732].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments